Sangamo Therapeutics Inc (NASDAQ: SGMO) Hogging The Spotlight Today

Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -24.07% and 22.43% over the past three months. SGMO shares are trading 0.49% year to date (YTD), with the 12-month market performance up to 103.05% higher. […]

Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?

Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -50.57% and 64.04% over the past three months. SGMO shares are trading 27.45% year to date (YTD), with the 12-month market performance up to 143.08% higher. […]

Sangamo Therapeutics Inc (SGMO) Volatility Spurs A Quest For Clarity

Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -5.26% and 170.18% over the past three months. SGMO shares are trading 330.70% year to date (YTD), with the 12-month market performance up to 290.65% higher. […]

Sangamo Therapeutics Inc (NASDAQ: SGMO): Hunting Genuine Value In Market Debris

Currently, there are 208.62M common shares owned by the public and among those 199.09M shares have been available to trade. The company’s stock has a 5-day price change of -9.64% and 158.04% over the past three months. SGMO shares are trading 339.90% year to date (YTD), with the 12-month market performance up to 516.77% higher. […]

Reassessing The Changing Outlook For Sangamo Therapeutics Inc (SGMO)

Currently, there are 208.62M common shares owned by the public and among those 199.09M shares have been available to trade. The company’s stock has a 5-day price change of 32.25% and 217.30% over the past three months. SGMO shares are trading 386.84% year to date (YTD), with the 12-month market performance up to 515.12% higher. […]

Gains May Be On The Menu For Sangamo Therapeutics Inc (NASDAQ: SGMO)

Currently, there are 208.62M common shares owned by the public and among those 199.07M shares have been available to trade. The company’s stock has a 5-day price change of -9.30% and 131.10% over the past three months. SGMO shares are trading 258.92% year to date (YTD), with the 12-month market performance up to 302.06% higher. […]

Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now

Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]

Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)

Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]

Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State

The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]